Karyopharm Therapeutics Inc at Jefferies Healthcare Conference Transcript
Everyone, my name is Maury Raycroft, and I'm one of the biotech analysts at Jefferies. I'm happy to introduce the CEO of Karyopharm, Richard Paulson; and the CMO of Karyopharm, Reshma Rangwala; and also the CFO is joining us too, Mike Mason. Thanks so much for joining us today for the fireside discussion.
Thank you, Maury. Thanks for having us.
Questions & Answers
Maybe to start off, for those who are new to the story, can you provide a 1-minute intro to Karyopharm and talk about key catalysts ahead in the next 6 to 12 months?
Sure. I mean when you look at Karyopharm, we're a global company and a fully integrated commercial-stage company with a foundation
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
